Since the signing of a framework agreement for research collaboration with the Clermont Auvergne University in 2021, various projects have been initiated with UCA laboratories.
Today, thanks to France Relance, NeoBioSys and the M2ISH laboratory have set themselves the task of finding out how the microbiota can improve the vaccine response.
This is one of the most upstream projects carried out by our company to date. NeoBioSys is therefore really happy to start this new adventure!
NeoBioSys® was born from the resolve of its two co-founders Nicolas Bourgne and Grégory Chambon to answer the issues of valorization and industrialization of production processes by biotechnology.
Contact us
Navigation
All rights reserved – Neobiosys 2022 – Legal Notice – Created by Coqpit, Digital Agency.
